View Press Releases
Principal Investigators Launches the World’s First Place for Clinical Trial & Patient Referral Offers.
WARSAW, POLAND - Jul 1, 2014 - Principal Investigators® (www.principalinvestigators.com), the
worlds first place for clinical trial & patient
referral offers, announced the global availability of its
online platform designed specifically to connect Medical
Doctors with Pharma and R&D companies involved in clinical
studies. With principalinvestigators.com all
medical doctors can start referring their patients and
increase their ability to start a new clinical trial at their
site. It allows Pharma & CRO companies to
locate investigators from all over the globe and carry out
feasibility all in one place. It also helps to locate MDs
referring their patients for planned or ongoing clinical
trials. Investigators can easily monitor offers, apply to
trials within their area of expertise and gain new business in
a fast and simple way.
These days more than 70% of clinical trials are 1-6 or more
months delayed due to the lack of patients and poorly
performing sites, which makes the life-saving medical
innovations unavailable on the market for more than it should
be. Principalinvestigators.com was
created to change that.
Planning is a crucial element in clinical trials which can
determine the success of any research. That's why principalinvestigators.com focuses
purely on the feasibility and patient
recruitment processes. This combination allows the
service to fill in the gap which the competition does not
provide and helps improve the overall trial enrollment
performance.
Principalinvestigators.com works
in a similar way to LinkedIn: MDs create and maintain
their professional profiles, collect references from Sponsors
& CROs which confirm their performance as a reliable
business partner. It currently maintains over 20,000 qualified
clinical trial investigators around the world and the
number is growing each day. "By having all our data input
directly by the investigators themselves and collecting
references from the Sponsors & CROs they cooperated with,
we can provide access to the most reliable and up-to-date
information on the market, including valid
contact details, professional experience, site
performance and facilities - this allows Sponsors & CROs
to make better decisions regarding patient recruitment plans
and site selection." says Adam Kogut - the creator and brain
behind principalinvestigators.com.
"We spoke to CROs and sponsor companies from all over the
world about the most problematic issues they face when it
comes to site enrolment and the afterwards. In 92% of all
cases it was the time spent on searching and having to go
through numerous and usually not up-to-date sources which
varied in data quality as well as the patient recruitment
plans being too optimistic. This is why we implemented
reference collections to prove which Investigators
are trustworthy, and a two-way investigator recruitment system
which basically comes down to searching throughout our unified
research center database, and posting trial and/or
patient referral offers, where investigators can directly
apply and go through the feasibility process. This
significantly reduces the time - by over 70% - providing
access to a large number of investigators potentially willing
to participate in a clinical trial, and eliminates
the common lack of interest (due to having a competitive
trial or other reasons) which was also an issue" says
Mike Dziurkowski - Marketing Manager at principalinvestigators.com.
Principalinvestigators.com was
created by Remean LLC. The founder and creator - Adam Kogut,
has been associated with the pharmaceutical industry for over
10 years providing the expertise in the field of clinical
research and accelerating the time-to-market for the
innovative treatments.